Can You Take Maxalt and Tadalafil Together?
Yes, you can take Maxalt (rizatriptan) and tadalafil together—there are no documented drug interactions between these medications and no contraindications to their concurrent use. However, both drugs have vasoconstrictive and vasodilatory effects respectively, requiring awareness of cardiovascular considerations.
Key Safety Considerations
Cardiovascular Screening is Critical
Before combining these medications, you must ensure the patient does not have:
- Ischemic heart disease (angina, prior MI, documented silent ischemia)
- Uncontrolled hypertension
- Coronary artery vasospasm (including Prinzmetal's variant angina)
- Other significant cardiovascular disease
Maxalt is absolutely contraindicated in patients with these conditions 1. This is non-negotiable.
Mechanism and Theoretical Concerns
Rizatriptan (Maxalt) works as a 5-HT1B/1D receptor agonist, causing vasoconstriction of intracranial blood vessels and inhibiting trigeminal nerve activation 2. This vasoconstrictive effect can theoretically affect any vascular bed:
- Life-threatening cardiac arrhythmias and death have been reported with 5-HT1 agonists 1
- Cerebrovascular events (stroke, hemorrhage) have occurred 1
- Peripheral vascular ischemia and even renal infarction have been documented with rizatriptan 3
- Blood pressure increases of 2-3 mmHg occur even in healthy subjects 1
Tadalafil causes vasodilation through PDE5 inhibition, primarily affecting pulmonary and systemic vasculature 4.
Why This Combination is Generally Safe
Despite opposing vascular effects, there is no pharmacokinetic interaction between these drugs:
- Rizatriptan reaches Tmax at approximately 1 hour with 45% bioavailability 2, 5
- Tadalafil has a long half-life (17+ hours for the 5mg daily formulation) 4
- Neither drug is listed in the FDA label as interacting with the other 1
- The vasodilatory effects of tadalafil are primarily in different vascular beds than rizatriptan's primary targets
Clinical Algorithm for Safe Co-Administration
Step 1: Cardiovascular Risk Assessment
- If ANY cardiovascular disease present → Do NOT prescribe Maxalt (absolute contraindication) 1
- If uncontrolled hypertension → Do NOT prescribe Maxalt 1
- If cardiovascular risk factors present → Consider cardiovascular evaluation before first dose 1
Step 2: Medication Timing Considerations
- No mandatory separation time required between doses
- Rizatriptan acts within 1-2 hours and is used intermittently for acute migraine 5, 6
- Tadalafil (especially 5mg daily) provides continuous effect 4
- Patients can take rizatriptan for migraine while on daily tadalafil therapy
Step 3: Drug Interaction Check
Ensure patient is NOT taking:
- MAO inhibitors (contraindicated with rizatriptan) 1
- Propranolol (requires rizatriptan dose reduction to 5mg) 1
- Ergot-containing drugs within 24 hours 1
- Other triptans within 24 hours 1
- Nitrates (contraindicated with tadalafil)
Step 4: Monitoring
- Monitor blood pressure, especially in first few uses 1
- Counsel patient on immediate emergency evaluation if chest pain, jaw pain, or neurological symptoms occur 1
- Watch for signs of peripheral ischemia (rare but reported) 3
Common Pitfalls to Avoid
- Don't assume "vasodilation cancels vasoconstriction" - these drugs act on different receptor systems and vascular beds
- Don't overlook subclinical cardiovascular disease - rizatriptan can unmask coronary disease 1
- Don't forget propranolol interaction - requires rizatriptan dose reduction 1
- Don't confuse migraine symptoms with cardiac symptoms - cerebrovascular events have been misidentified as migraine 1
Bottom Line
The combination is pharmacologically safe in cardiovascularly healthy patients. The FDA label for Maxalt does not list tadalafil as an interacting drug, and no case reports or studies document problems with this combination. The primary concern is ensuring rizatriptan itself is appropriate for the patient based on cardiovascular status, which is independent of tadalafil use 1.